CatallaxCore
← Back to bills

HB 26-1262

signed

Patient Access to Compounded Medical Items

Plain-English Summary

AI-generated

House Bill 26-1262, known as "Patient Access to Compounded Medical Items," allows licensed healthcare professionals in Colorado to mix or create personalized medications (compounding) under federal and state laws. It also permits pharmacies and specialized facilities to supply these compounded drugs to doctors, hospitals, and other medical providers. The bill ensures that the state’s pharmacy board cannot impose stricter rules than what is already set by federal and state regulations. This means patients will have better access to customized medications tailored to their specific needs. Since it has been signed into law, this legislation is now active and enforceable in Colorado.

Official Summary

The bill provides that, if the action is undertaken in accordance with applicable federal and state law:A licensed person may compound a drug or device in the state;A state-licensed pharmacy or a distribution facility registered with the federal food and drug administration (licensed 503B outsourcing facility) may supply a compounded drug or device to a licensed health-care provider, pharmacy, facility, or organization; andA licensed health-care provider, pharmacy, facility, or organization may obtain, dispense, or administer a compounded drug or device supplied by a state-licensed pharmacy or a licensed 503B outsourcing facility.     In addition, the bill prohibits the state board of pharmacy from adopting rules that are more restrictive than federal or state law regarding the compounding of drugs or devices.     Current law exempts drugs that are intended solely for investigational use by experts qualified by scientific training and experience and that are plainly labeled for investigational use only from the sales and delivery prohibition for new drugs. The bill also exempts from the prohibition:Drugs that are reviewed by an institutional review board and plainly labeled for investigational use only; andCompounded drugs and devices if the compounding of the drug or device is undertaken in accordance with applicable federal and state law.(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

Details

Chamber
House
First action
2026-04-21
Latest action
2026-02-19
Last action desc.
Introduced In House - Assigned to Health & Human Services
OpenStates
View source ↗

Topics

Health Care & Health InsuranceProfessions & Occupations

Votes

CONCUR
2026-04-21 · Senate · passYes: · No: · Other:
REPASS
2026-04-21 · Senate · passYes: · No: · Other:
Adopt amendment L.007 (Attachment E).
2026-04-09 · Senate · passYes: · No: · Other:
Refer House Bill 26-1262, as amended, to the Committee of the Whole and with a recommendation that it be placed on the consent calendar.
2026-04-09 · Senate · passYes: · No: · Other:
BILL
2026-03-16 · House · passYes: · No: · Other:
AMD (H.002)
2026-03-13 · House · failYes: · No: · Other:
AMD (H.001)
2026-03-13 · House · failYes: · No: · Other:
Refer House Bill 26-1262 to the Committee of the Whole.
2026-03-10 · House · passYes: · No: · Other: